Live
- New SCoR railway zone going to be a reality
- Trivikram hints at Samantha’s return to Telugu cinema at ‘Jigra’pre-release event
- Patnama Mahender Reddy Takes Charge as Government Chief Whip in Legislative Council
- CERT-In Issues Critical Warning for Microsoft Edge Users: Update Now
- Eight foreign tourists injured in road accident in Bihar
- A Comprehensive Guide to Women's Health- Blood Tests in Gynaecology
- Bipasha Basu reveals daughter Devi’s ‘favourite book’
- MP Putta Mahesh Kumar thanks PM Modi for funding Polavaram
- Bengaluru Police Launch Aggressive Anti-Drug Campaign, Netting Significant Arrests And Seizures
- Virtual Reality and Augmented Reality reshaping Dubai's real estate industry
Dr Reddy's Laboratories launches cholesterol lowering drug in US
Dr Reddy\'s Laboratories today said it has launched generic Ezetimibe and Simvastatin tablets, used for reducing cholesterol, in the US market.
Dr Reddys Laboratories today said it has launched generic Ezetimibe and Simvastatin tablets, used for reducing cholesterol, in the US market.
The company has launched Ezetimibe and Simvastatin tablets in the strengths of 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg and 10 mg/80 mg in the US market, Dr Reddys Laboratories said in a BSE filing.
The product is a generic version of MSD International GmbHs Vytorin tablets, it added.
"Dr Reddys is among the first companies to launch the generic product in the US," the company said.
According to IMS Health, Vytorin brand had the US sales of approximately USD 678 million MAT for the most recent 12 months ended February 2017, it added.
Shares of the company were trading 0.44 per cent down at Rs 2,599.50 on BSE.
